Legal Representation
Attorney
Kimberly Jarman, Esq.
USPTO Deadlines
Next Deadline
118 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2019-11-05)
Due Date
November 05, 2025
Grace Period Ends
May 05, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
45 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 26, 2025 | E815 | I | TEAS SECTION 8 & 15 RECEIVED |
| Nov 5, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Oct 28, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Oct 28, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Oct 28, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Oct 28, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Oct 28, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Dec 30, 2019 | COC. | O | CORRECTION UNDER SECTION 7 - PROCESSED |
| Dec 30, 2019 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Nov 18, 2019 | ES7R | I | TEAS SECTION 7 REQUEST RECEIVED |
| Nov 5, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Oct 1, 2019 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Sep 30, 2019 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Sep 4, 2019 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Aug 27, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jul 31, 2019 | IUAF | S | USE AMENDMENT FILED |
| Jul 31, 2019 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Jun 11, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jun 7, 2019 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Jun 7, 2019 | EXT3 | S | SOU EXTENSION 3 FILED |
| Jun 7, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 15, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 13, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Nov 13, 2018 | EXT2 | S | SOU EXTENSION 2 FILED |
| Nov 13, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 1, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Apr 27, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Apr 27, 2018 | EXT1 | S | SOU EXTENSION 1 FILED |
| Apr 27, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Apr 18, 2018 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Dec 23, 2017 | CHPN | I | POST PUBLICATION AMENDMENT – NOT ENTERED |
| Dec 22, 2017 | APET | A | ASSIGNED TO PETITION STAFF |
| Dec 12, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Dec 8, 2017 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Oct 26, 2017 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Oct 17, 2017 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Oct 17, 2017 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| May 18, 2017 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Apr 18, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 18, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 29, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 4, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Mar 3, 2017 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 13, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jan 10, 2017 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Injectable drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals via injection into the posterior chamber of the eye for the treatment of diseases and conditions, including ocular diseases, namely, uveitis and retinal disease
First Use Anywhere:
May 10, 2019
First Use in Commerce:
May 10, 2019
Class 010
Injectable sustained drug delivery systems for delivering pharmaceuticals via injection into the posterior chamber of the eye
First Use Anywhere:
May 10, 2019
First Use in Commerce:
May 10, 2019
Additional Information
Other
In the statement, line 4, through line 8, should be deleted, and injectable drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals via injection into the posterior chamber of the eye for the treatment of diseases and conditions, including ocular diseases, namely, uveitis and retinal disease should be inserted. In the statement, line 10 is deleted, and injectable sustained drug delivery systems for delivering pharmaceuticals via injection into the posterior chamber of the eye is inserted.
Classification
International Classes
005
010